Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 13

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 13
---
 can perform while providing treatment customized based on patient conditions.

With its established client
service history, accumulated experience as well as its continuous upgrades and development of treatment models, NewGenIvf believes that
it will be able to better monetize its brands through its business.

Experienced Management Team

The NewGenIvf management
team has considerable experience in the ARS market and the broader healthcare industry. A considerable number of NewGenIvf’s management
are physicians or laboratory technicians who possess extensive experience in the ARS industry and are experts in their respective fields.
NewGenIvf’s Chief Executive Officer, Mr. Alfred Siu, has more than 13 years of experience in the fertility service market.
Dr. Wiphawee Luangtangvarodom had over 8 years of experience as an obstetrician and gynecologist. NewGenIvf’s two lab
supervisors, Ms. Anussara Phinyong, and Ms. Araya Boonchaisitthipong, each had over eight years of experience in the embryologist
field. These individuals have extensive experience in managing assisted reproductive medical facilities. NewGenIvf is also led by other
members of the professional management team, who are intimately involved in the operational and financial management of NewGenIvf’s
Group. Leveraging their experience, NewGenIvf believes that it is well positioned to expand its network and aims to become a leader in
the Asia Pacific ARS market.

Strategies

NewGenIvf’s vision
is to provide tailored ARS solutions to fulfil patients’ dreams of becoming a parent. To realize this vision, NewGenIvf plans to
adopt the following strategies:

Offer Broad Fertility Services for Fertility Tourists across Asia Pacific

NewGenIvf intends to provide
broad fertility services for fertility tourists seeking high quality, cost effective and comprehensive fertility solutions. According
to CIC, the demand for fertility tourism is driven by a variety of factors including the prevalence of infertility, the introduction
of the Three-Child policy in China, the improved understanding of assisted reproductive technology and increased affordability of ARS. To
address these needs, NewGenIvf plans to offer its customers a “hassle-free”, seamless and integrated ARS and hospitality
arrangement experience. To complement its fertility services, NewGenIvf intends to integrate its offerings with additional services for
traveling patients, most of whom are first-time fertility tourists, such as translation service, hotel arrangement and